Increasing Diversity in Clinical Trials Using Deep 6 AI

As technology has developed over time, we can reach new populations who had not had prior access to certain medical care, including clinical trials. We’re also able to use it to counteract the effects of the human biases that have led to today’s gaps in trial participant diversity. AI can carry out functions that were previously only done manually, which significantly decreases the effects of inequitable practices and limited outreach to wider populations. Deep 6 AI is the leader in precision research software, connecting all research stakeholders in an AI-powered, real-time, data-driven, collaborative ecosystem. Using Deep 6 AI, experts can widen eligibility criteria as a way to potentially increase trial diversity for comorbidities that disproportionately affect diverse patient populations.